Open access
Open access
Powered by Google Translator Translator

Chest Medicine

Review: Pharmacologic Treatments for COVID-19

14 Apr, 2020 | 03:05h | UTC

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review – JAMA

 


Video: New York City Coronavirus (COVID-19) Update

14 Apr, 2020 | 03:03h | UTC

New York City Coronavirus (COVID-19) Update – JAMA

 


Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic

14 Apr, 2020 | 03:00h | UTC

Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic – Journal of the American College of Surgeons

 


Commentary on the New IDSA’s COVID-19 Treatment Guidelines

14 Apr, 2020 | 02:49h | UTC

IDSA’s COVID-19 Treatment Guidelines Highlight Difficulty of “Don’t Just Do Something, Stand There” – HIV and ID Observations Blog

See Original Guideline: Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

 


Study Validates Loss of Smell and Taste as Symptoms of Covid-19

14 Apr, 2020 | 02:57h | UTC

Association of chemosensory dysfunction and Covid‐19 in patients presenting with influenza‐like symptoms – International Forum of Allergy & Rhinology

Commentary: Loss of smell and taste validated as COVID-19 symptoms in patients with high recovery rate – University of California

 


Face Masks Against COVID-19: An Evidence Review

14 Apr, 2020 | 02:52h | UTC

Face Masks Against COVID-19: An Evidence Review – Preprints

Related Analysis: Face Masks for the Public During the Covid-19 Crisis

 


Richard Lehman’s Covid-19 Reviews

14 Apr, 2020 | 02:46h | UTC

Richard Lehman’s covid-19 reviews—13 April 2020 – The BMJ Opinion

“In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19.”

 


IDSA Guidelines on the Treatment and Management of Patients with COVID-19 Infection

13 Apr, 2020 | 00:27h | UTC

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

 

Related Commentary on Twitter

 


Compassionate Use of Remdesivir for Patients with Severe Covid-19

13 Apr, 2020 | 00:23h | UTC

Compassionate Use of Remdesivir for Patients with Severe Covid-19 – New England Journal of Medicine

Commentaries: PulmCrit – Eleven reasons the NEJM paper on remdesivir reveals nothing AND Expert reaction to a study about compassionate use of remdesivir for patients with severe COVID-19 – Science Media Centre AND What Do the New Remdesivir Data Mean? – Science Translational Medicine

 


Possible Algorithm to Empiric Anticoagulation in COVID-19 Based on D-Dimer

13 Apr, 2020 | 00:20h | UTC

D-dimer cutoffs to predict thrombosis in COVID-19 – PulmCrit

Note: this link is not an endorsement of the algorithm.

Related Guidance: Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19 – Thrombosis UK AND ISTH interim guidance on recognition and management of coagulopathy – Journal of Thrombosis and Haemostasis

 


Incidence of Thrombotic Complications in Critically ill ICU Patients with COVID-19

13 Apr, 2020 | 00:22h | UTC

Incidence of thrombotic complications in critically ill ICU patients with COVID-19 – Thrombosis Research

Related Observational Studies: Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia – Journal of Thrombosis and Haemostasis AND Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy – Journal of Thrombosis and Haemostasis AND Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia – Journal of Thrombosis and Haemostasis

 


Implementation Guide: Optimizing Medication Management during the COVID-19 Pandemic

13 Apr, 2020 | 00:18h | UTC

Optimizing Medication Management during the COVID-19 Pandemic: Implementation Guide for Post-Acute and Long-Term Care – University of Maryland School of Pharmacy

 

Related Commentary on Twitter

 


Studies: Obesity Increases the Risk of Complications in Patients with Covid-19

13 Apr, 2020 | 00:14h | UTC

1 – High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation – Obesity

2 – Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission – Clinical Infectious Diseases AND Commentary: In New York, obesity appears to raise COVID-19 risk – CIDRAP

 


Mechanical Ventilators Adapted from BiPAP machines?

13 Apr, 2020 | 00:17h | UTC

See instructions and protocols developed by Mount Sinai Health System: Repurposing bi-level ventilators for use with intubated patients while minimizing risk to health care works during insufficient supply of conventional ventilation for patients with COVID-19

We want to learn more about this interesting initiative!

 


Study: Antibody Tests Reveal 14% are Immune to Covid-19 in German Town

13 Apr, 2020 | 00:10h | UTC

The original report can be found here (in German)

 


Studies: Diabetes Increases the Risk of Complications in Patients with Covid-19

13 Apr, 2020 | 00:12h | UTC

1 – Prevalence and impact of diabetes among people infected with SARS-CoV-2 – Journal of Endocrinological Investigation AND Commentary: Diabetes Could Increase Severity of COVID-19, Including Risk of ICU Admission and Death – MedicalResearch.com

2 – Evidence Reviews: Diabetes and risks from COVID-19 – CEBM University of Oxford AND Managing diabetes during the COVID-19 pandemic – CEBM University of Oxford

 


[Preprint] Factors Associated with Worse Outcomes Among 4,103 Patients with COVID-19 in New York City

13 Apr, 2020 | 00:09h | UTC

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City – medRxiv

 


Opinion – BCG Against Coronavirus: Less Hype and More Evidence, Please

13 Apr, 2020 | 00:06h | UTC

See new Preprints suggesting caution in correlating BCG vaccination policies with COVID-19 incidence and mortality:

See previous studies suggesting a benefit from BCG vaccination:

 


Updated Guidance on Personal Protective Equipment (PPE) for Clinicians

13 Apr, 2020 | 00:02h | UTC

Updated guidance on Personal Protective Equipment (PPE) for clinicians – Intensive Care Society

Related: Clinical guidance for intensive care and anesthetics AND COVID-19: guidance for health professionals – GOV.UK

 


COVID-19 Testing: The Threat of False-Negative Results

13 Apr, 2020 | 00:04h | UTC

COVID-19 Testing: The Threat of False-Negative Results – Mayo Clinic Proceedings

Commentary: False-negative COVID-19 test results may lead to false sense of security – Mayo Clinic

 


New Clinical Score: Prediction for Progression Risk in Patients with COVID-19 Pneumonia

12 Apr, 2020 | 23:58h | UTC

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score – Clinical Infectious Diseases

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score – Comorbidity; older Age; Lower lymphocyte; and higher Lactate dehydrogenase at presentation were independent high-risk factors for COVID-19 progression. (via @veselov78 see Tweet)

Related: Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal – The BMJ

 


NICE Publishes new COVID-19 Guidelines on Cystic Fibrosis, COPD and Dermatological Conditions

10 Apr, 2020 | 03:22h | UTC

News Release: NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease (COPD) and dermatological conditions – National Institute for Health and Care Excellence

See New COVID-19 Rapid Guidelines: Community-based care of patients with chronic obstructive pulmonary disease (COPD) AND Cystic fibrosis AND Dermatological conditions treated with drugs affecting the immune response

See Other COVID-19 Rapid Guidelines: Severe asthma AND Managing suspected or confirmed pneumonia in adults in the community AND Rheumatological autoimmune, inflammatory and metabolic bone disorders AND Managing symptoms (including at the end of life) in the community AND Critical care in adults AND Hematopoietic stem cell transplantation AND Dialysis service delivery AND Delivery of radiotherapy AND Delivery of systemic anticancer treatments

 


Meta-Analysis: Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples

10 Apr, 2020 | 03:03h | UTC

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis – Gastroenterology

Commentary: Gastrointestinal Aspects of COVID-19 – NEJM Journal Watch

 


Analysis: Face Masks for the Public During the Covid-19 Crisis

10 Apr, 2020 | 02:58h | UTC

Face masks for the public during the covid-19 crisis – The BMJ

Commentary: Time to encourage people to wear face masks as a precaution, say experts – The BMJ

Related: Covid-19: What is the evidence for cloth masks? – The BMJ AND Covid-19: Should cloth masks be used by healthcare workers as a last resort? – The BMJ

“- The precautionary principle states we should sometimes act without definitive evidence, just in case

– Whether masks will reduce transmission of covid-19 in the general public is contested

– Even limited protection could prevent some transmission of covid-19 and save lives

– Because covid-19 is such a serious threat, wearing masks in public should be advised”

See also: CDC Now Recommends Wearing Cloth Face Coverings in Public Settings (statement and commentaries)

 


Managing the Supportive Care Needs of Those Affected by COVID-19

10 Apr, 2020 | 03:01h | UTC

Managing the supportive care needs of those affected by COVID-19 – European Respiratory Journal

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.